Aug. 21 at 10:04 AM
$CTMX Rough days! Be patient. The timeline is working in our favor.
Enrollment for the expansion cohorts was completed in August 2025. It took ~ five months for the mPFS data to mature, with the data cutoff occurring in mid January. The company then spent roughly two months analyzing and packaging the interim data before releasing it on March 16.
For the optimization cohorts, enrollment was completed in April 2026. Assuming a similar timeline, approximately five months for the mPFS data to mature, followed by up to two months for data analysis and preparation, the mPFS data could become available by mid to late November.
If the mOS data from the dose escalation and expansion cohorts are also mature by then(15 months after completion of enrollment), which I believe is quite possible, we could see the company release both the mPFS and mOS data during the Q3 earnings call (likely in mid Nov).
